CAMBRIDGE, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Results demonstrate potential of Company’s therapies developed using its novel Shielded Living Therapeutics™ platform to treat broad range of chronic diseasesCAMBRIDGE,...
LOS ANGELES, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS: CMGR) (“Clubhouse Media” or...
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused...
Building on the successful hospital-focused launch of NUZYRA, Paratek is expanding commercial promotion of NUZYRA into the community setting aimed...
World’s Largest Provider of HIV/AIDS Medical Care Will Implement ScriptMed® Cloud to Improve Clinical Outcomes for PatientsBOWIE, Md., Feb. 08,...
Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in...
TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a...
ROCKVILLE, MD, Feb. 08, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and...
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at...
New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a...
Thomas G. Wiggans appointed ChairmanSOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical...
Conference Call and Webcast To be Held Thursday, February 11, 2021 4:30 pm Eastern TimeNEW YORK, Feb. 08, 2021 (GLOBE...
NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous...
Pre-IND Meeting Written Response from FDA Provides Guidance on Product Development and Clinical Testing Protocol Intradermal Test is Designed to...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 08, 2021 (GLOBE...
- Phase 1/2 trial expected to commence in first half of 2021 - Company has three INDs cleared for rare...
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
SUWON, Republic of Korea, Feb. 08, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...
Targeting initiation of dose confirmation trial by end of 2021 with data readout by end of 2022 Initiation of Phase 3...